Galectin Therapeutics Inc. is a biotechnology company that is focused on developing therapies to improve the lives of patients with fibrotic disease, chronic liver disease and cancer. The Company’s product candidates include galectin-3 inhibitor, whi... Read more
Yahoo
MarketWatch
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.